Abstract
The role of complement in immunoglobulin G-triggered inflammation was studied in mice genetically deficient in complement components C3 and C4. Using the reverse passive Arthus reaction and experimental models of immune hemolytic anemia and immune thrombocytopenia, we show that these mice have types II and III inflammatory responses that are indistinguishable from those of wild-type animals. Complement-deficient and wild-type animals exhibit comparable levels of erythrophagocytosis and platelet clearance in response to cytotoxic anti-red blood cell and antiplatelet antibodies. Furthermore, in the reverse passive Arthus reaction, soluble immune complexes induce equivalent levels of hemmorhage, edema, and neutrophillic infiltration in complement-deficient and wild-type animals. In contrast, mice that are genetically deficient in the expression of Fc receptors exhibit grossly diminished reactions by both cytotoxic antibodies and soluble immune complexes. These studies provide strong evidence that the activation of cell-based Fc gamma R receptors, but not complement, are required for antibody-triggered murine inflammatory responses.
MeSH Terms
Anemia, Hemolytic/immunology
Animals
Blood Platelets/immunology
Complement C3/deficiency,immunology
Complement C4/deficiency,immunology
Erythrocytes/immunology
Immunoglobulin G/immunology
Inflammation/immunology
Mice
Mice, Knockout
Neutrophils/immunology,physiology
Phagocytosis
Rabbits
Thrombocytopenia/immunology
Chemicals
Complement C3
Complement C4
Immunoglobulin G
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Sylvestre D
Division of Molecular Biology, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.
Clynes R
Ma M
Warren H
Carroll M C
Ravetch J V
References (21)
21 references, click to expand
-
BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS.
J Exp Med. 1965 Feb 1;121:215-34
PMID: 14264268
-
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
Lancet. 1994 Sep 10;344(8924):703-7
PMID: 7915773
-
The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
J Exp Med. 1968 Feb 1;127(2):371-86
PMID: 4383923
-
Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
J Immunol. 1970 Jul;105(1):55-69
PMID: 4246566
-
Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
J Clin Invest. 1972 Mar;51(3):575-82
PMID: 4536807
-
Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.
J Invest Dermatol. 1982 Mar;78(3):206-9
PMID: 6276474
-
Effect of intravenous immunoglobulin in immune thrombocytopenia.
Lancet. 1983 Jul 23;2(8343):193-5
PMID: 6135031
-
Monoclonal antibody-induced murine hemolytic anemia.
J Lab Clin Med. 1984 Oct;104(4):591-601
PMID: 6481219
-
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody.
N Engl J Med. 1986 May 8;314(19):1236-9
PMID: 2939345
-
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.
Science. 1990 Jul 13;249(4965):146-51
PMID: 2371562
-
Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms.
Int Immunol. 1990;2(12):1133-41
PMID: 2090198
-
Augmentation of reverse arthus reaction by mast cells in mice.
J Clin Invest. 1991 Sep;88(3):841-6
PMID: 1832174
-
The role of complement, platelet-activating factor and leukotriene B4 in a reversed passive Arthus reaction.
Br J Pharmacol. 1992 Sep;107(1):44-9
PMID: 1330163
-
Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient.
Blood. 1993 Jan 1;81(1):15-9
PMID: 8093346
-
Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB)F1 mice.
Blood. 1993 Aug 1;82(3):837-44
PMID: 8338948
-
Cytotoxic antibodies trigger inflammation through Fc receptors.
Immunity. 1995 Jul;3(1):21-6
PMID: 7621075
-
Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura.
Lancet. 1993 Oct 16;342(8877):945-9
PMID: 8105212
-
FcR gamma chain deletion results in pleiotrophic effector cell defects.
Cell. 1994 Feb 11;76(3):519-29
PMID: 8313472
-
Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade.
Science. 1994 Aug 19;265(5175):1095-8
PMID: 8066448
-
Fc receptors: rubor redux.
Cell. 1994 Aug 26;78(4):553-60
PMID: 8069908
-
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11490-4
PMID: 8524789